Skip To Content
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.
Before it's here, it's on the Bloomberg Terminal.
Learn More
AGN:USNew York

Allergan PLC

COMPANY INFO
158.25USD
+1.91+1.22%
Market Closed
As of 08/16/2019 EDT
Open
157.03
Prev Close
156.34
Volume
3,024,148
Market Cap
51.911B
Day Range
156.75158.64
52 Week Range
114.27197.00
1D1M1Y5Y
View Full Chart
Market Closed
As of 08/16/2019 EDT
1D1M1Y5Y
View Full Chart
News
Press Releases
View More
markets
AbbVie Shares Tumble After $63 Billion Allergan Deal
Before it's here, it's on the Bloomberg Terminal.
Learn More
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.

Key Statistics

P/E Ratio--
Bloomberg (BEst) P/E Ratio9.5602
Bloomberg (BEst) PEG Ratio1.8331
Shares Outstanding328.03M
Price to Book Ratio0.8696
Price to Sales Ratio3.3653
1 Year Return-13.03%
30 Day Avg Volume4,808,418
EPS-1.75
Bloomberg (BEst) EPS Curr Yr16.6820
Dividend1.87%
Last Dividend Reported0.74
Earnings Announcement for Period Ending Q3/2019:10/28/2019

Compare
1-Day Performance

0+2%
0+2%
Equity
AGN:US
+1.22%
Sponsored By

About Allergan PLC

Allergan PLC manufactures specialty pharmaceuticals. The Company develops, manufactures, and distributes generic, brand, and over-the-counter products. Allergan offers its pharmaceutical drugs around the world.
Address
5 Giralda Farms Madison, NJ 07940 United States
Phone
1-862-261-7000
Website
www.allergan.com

Income Statement

Quarterly
Annual
;
Q2 2019 (Millions USD)
  • Revenue
    4,090.10
  • Net Income
    -1,759.00
  • Profit Margin
    -43.01%

Balance Sheet

Quarterly
Annual
;
Q2 2019 (Millions USD)
  • Total Assets
    95,480.70
  • Total Liabilities
    35,784.60
  • Debt to Assets
    24.34%

Cash Flow

Quarterly
Annual
Q2 2019 (Millions USD)
  • Operating
    1,410.30
  • Investing
    567.40
  • Financing
    -1,114.80